EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Feasibility and Tumor Dynamics of Daily MRI ‐Guided Online Adaptive Radiotherapy for Brain Glioma

Shouliang Ding, Xiumao Yin, Mengqi Sun iD, Hongdong Liu, Ying Wang, Biaoshui Liu, Mengke Qi, Yuchuan Zhou, Xiaojing Du, Meiling Deng, Wanming Hu iD, Xiaoyan Huang und 3 weitere

CNS Neuroscience & Therapeutics · 2026

DOI: 10.1002/cns.70905 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Shouliang Ding und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-…. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Magnetic Resonance Imaging, Radiotherapy, Image-Guided. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Clinical Research 5010 Program, Sun Yat-sen University, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Magnetic resonance image (MRI)‐guided radiotherapy can optimize the therapeutic outcomes of brain glioma patients, as it adjusts to tumor changes in the course of radiation treatment. This study evaluates the dynamic changes of tumors and the feasibility of implementing MRI‐guided online adaptive radiotherapy (MRIgOART) for the treatment of brain glioma. Patients & Methods This observational prospective cohort study involved patients with brain glioma treated using 1.5 T MR‐Linac from 2021 to 2023. MRIgOART can correct treatment errors and evaluate treatment response through adapt‐to‐position (ATP) and adapt‐to‐shape (ATS) strategies. Dice similarity coefficient (DSC), absolute/relative volume (Vrel), and Hausdorff distance (HD) metrics were used to quantify tumor changes. The covariables subjected to evaluation included: surgical resection extent, 1p/19q status, telomerase reverse transcriptase (TERT) mutation status, O6‐methylguanine‐DNA‐methyltransferase (MGMT) methylation status, and isocitrate dehydrogenase (IDH) mutation status. ART and non‐ART treatment plans were comparatively analyzed based on target coverage and dose constraints for normal brain tissue. The pattern of failure, as the primary endpoint, was evaluated in this study. Secondary endpoints of the study consisted of overall survival (OS) and progression‐free survival (PFS), assessed according to treatment schedules.

Results

The cohort comprised 57 patients. The patients with an interval longer than 10 days from simulation to the Fx1 exhibited more significant tumor changes ( p < 0.001). The tumor volume showed a gradual reduction during the treatment, whereas the alterations in its location and shape became increasingly evident over time. Multivariate analyses identified associations between prognosis and HD, in addition to a relationship between the extent of surgical resection and DSC. ATS was utilized in 52.6% of patients at least once during treatment, with a higher frequency in TERT wild‐type patients ( p = 0.013). MRIgOART treatment plans achieved superior target conformality, adequate coverage, and effective sparing of OARs. High‐grade glioma (HGG) patients exhibited median PFS of 13 months (95% CI, 10.2–15.8 months) and OS of 28 months (95% CI, 23.3–32.7 months). Failure analysis revealed 58.9% in‐field, 17.6% marginal, and 23.5% distant recurrences, with IDH mutation status associated with failure patterns.

Conclusion

Preliminary findings in patients with HGG suggest a lower incidence of recurrences within the radiation field and indicate promising outcomes associated with MRIgOART. However, these observations require further validation through comparative studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsMagnetic Resonance ImagingRadiotherapy, Image-GuidedHumansMaleFemaleMiddle AgedFeasibility StudiesAdultProspective StudiesAgedCohort StudiesTreatment Outcome

Stichwörter der Autor:innen

MR‐Linacadaptive radiotherapybrain gliomafeasibilitytumor dynamics

Autor:innen und Institutionen

  • Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • United Laboratory of Frontier Radiotherapy Technology of Sun Yat-Sen University & Chinese Academy of Sciences Ion Medical Technology co., Ltd, Guangzhou, China.
  • Cancer Center, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, China.
  • Department of Radiation Oncology, Shenzhen People's Hospital, Shenzhen, China.
  • Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Department of Neurosurgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.

ORCID-Profile: Mengqi Sun, Wanming Hu, Yuanyuan Chen

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities, Clinical Research 5010 Program, Sun Yat-sen University
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Ding, S., Yin, X., Sun, M., Liu, H., Wang, Y., Liu, B., Qi, M., Zhou, Y., Du, X., Deng, M., Hu, W., Huang, X., Li, Z., Mou, Y., & Chen, Y. (2026). Feasibility and Tumor Dynamics of Daily MRI ‐Guided Online Adaptive Radiotherapy for Brain Glioma. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70905

Vancouver

Ding S, Yin X, Sun M, Liu H, Wang Y, Liu B, et al. Feasibility and Tumor Dynamics of Daily MRI ‐Guided Online Adaptive Radiotherapy for Brain Glioma. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70905

BibTeX
@article{Ding2026,
  author = {Ding, Shouliang and Yin, Xiumao and Sun, Mengqi and Liu, Hongdong and Wang, Ying and Liu, Biaoshui and Qi, Mengke and Zhou, Yuchuan and Du, Xiaojing and Deng, Meiling and Hu, Wanming and Huang, Xiaoyan and Li, Zihuang and Mou, Yonggao and Chen, Yuanyuan},
  title = {Feasibility and Tumor Dynamics of Daily MRI ‐Guided Online Adaptive Radiotherapy for Brain Glioma},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  doi = {10.1002/cns.70905}
}
Kostenlos starten →